The co clarified the situation for me. They haven't filed.
The timeline in the March update showed Q3 2015 approval for pancreatic cancer. To me, the arrow continuity implies that CE Mark was filed at some time before H2 2014
The CE Mark for pancreatic hasn't actually been filed yet, and today's announcement is the real situation.
Either I'm reading too much into their chart, or it really is misleading. Explains why I could never find a filing announcement.
Ann: OncoSil HCC Announcement, page-3
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.4¢ | $24.84K | 1.794M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 13454286 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 8386017 | 12 |
View Market Depth
| Last trade - 13.22pm 03/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |